SCHEMBL9813725

SCHEMBL9813725

Cc1cccc(Cl)c1NC(=O)/C=C1\SCC(=O)N1c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 4/20 0.43
▸ ALDH1A1 P00352 3/20 0.43
▸ MEN1 O00255 3/20 0.43
▸ GAA P10253 3/20 0.43
▸ MAPT P10636 2/20 0.43
▸ TDP1 Q9NUW8 1/20 0.41
▸ PSMD14 O00487 1/20 0.41
▸ LCK P06239 5/20 0.40
▸ MAPK14 Q16539 3/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.39
▸ RXFP1 Q9HBX9 1/20 0.39
▸ MAPK13 O15264 1/20 0.38
▸ EGFR P00533 1/20 0.38
▸ FYN P06241 1/20 0.38
▸ HCK P08631 1/20 0.38
▸ SRC P12931 1/20 0.38
▸ JAK3 P52333 1/20 0.38
▸ MAPK12 P53778 1/20 0.38
▸ MAPK11 Q15759 1/20 0.38
▸ PDK1 Q15118 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10852036 1.00 KMT2A (0.43) KMT2AALDH1A1MEN1GAAMAPT
SCHEMBL10849384 0.92 ALDH1A1 (0.47) KMT2AALDH1A1MEN1GAAMAPT
SCHEMBL10849390 0.92 ALDH1A1 (0.47) KMT2AALDH1A1MEN1GAAMAPT
Ralitoline SCHEMBL635346 0.84 PSMD14 (0.55) ALDH1A1GAATDP1PSMD14LCK
Ralitoline SCHEMBL9813595 0.84 PSMD14 (0.55) ALDH1A1GAATDP1PSMD14LCK
SCHEMBL9813551 0.77 ALDH1A1 (0.59) KMT2AALDH1A1MEN1GAAMAPT
SCHEMBL9813552 0.77 ALDH1A1 (0.59) KMT2AALDH1A1MEN1GAAMAPT
SCHEMBL9813560 0.76 LMNA (0.49) KMT2AALDH1A1MAPTTDP1PSMD14
SCHEMBL9813563 0.76 LMNA (0.49) KMT2AALDH1A1MAPTTDP1PSMD14
SCHEMBL9813566 0.76 PSMD14 (0.61) KMT2AALDH1A1MEN1GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0124911-B1 4-OXO-THIAZOLIDIN-2-YLIDEN-ACETAMIDE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND MEDICAMENTS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM ILLNESSES CONTAINING THEM GÖDECKE AKTIENGESELLSCHAFT (DE) 1991-07-31 — — EP disclosed
US-4563471-A CENTRAL NERVOUS SYSTEM DISORDERS WARNER-LAMBERT COMPANY (US) 1986-01-07 — — US disclosed
EP-0124911-A2 4-Oxo-thiazolidin-2-yliden-acetamide derivatives, process for their preparation, and medicaments for the treatment of central nervous system illnesses containing them GÖDECKE AKTIENGESELLSCHAFT (DE) 1984-11-14 — — EP disclosed
Send feedback